EXECUTIVE SUMMARY: The full spectrum of toxic substances dealt with at the Syrian Scientific Studies and Research Center (SSRC) is unknown. Alongside typical chemical warfare agents, snake venoms are an additional component, allegedly only as a means to manufacture anti-venom sera. The characteristics of a concrete serial product brought out within that context may point to a significant activity of SSRC.
A scientific paper published recently by the Department of Emergency Medicine at the American University of Beirut Medical Center revealed that a biomedical product manufactured serially by the Syrian Scientific Studies and Research Center (SSRC) contains polyvalent anti-serum to be used as an emergency treatment against the venoms of six snakes. The snakes are the Indian cobra, the Levant viper, the saw-scaled viper, the Israeli viper, the sand viper, and the horned desert viper. Named Antivenom-2, the anti-serum is prepared from pure plasma separated from the blood of healthy horses that are immunized by the venoms. This implies that the venoms have been obtained and accumulated by SSRC.
The anti-serum vial volume is 10 ml with a protein content of 3.5% and preservative in the form of m-cresol 0.15%. The anti-serum is stored at 2°C-8°C and has a shelf life of 18 months.